3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Schistosoma Mansoni: new trials by email Literature Review of Schistosoma Mansoni trials Research Report on Schistosoma Mansoni
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 400 | 2021-05-06 | 2022-07-12 |
| Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children Praziquantel, Artesunate + Mefloquine - Schistosoma Haematobium, Schistosoma Mansoni | Phase 3 | Completed | Institute of Tropical Medicine, Belgium | 726 | 2019-10-14 | 2021-04-05 |
| A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni | Phase 3 | Completed | Kenya Medical Research Institute | 212 | 2009-10-01 | 2010-01-22 |
Schistosomiasis (3) · Schistosomiasis haematobia (1)
Helminthiasis (3) · Infections (3) · Parasitic Diseases (3) · Trematode Infections (3) · Vector Borne Diseases (3) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Urinary Tract Infections (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Praziquantel (3) · Artesunate (1) · Mefloquine (1) · Pyrimethamine (1)
Kenya Medical Research Institute (2) · Institute of Tropical Medicine, Belgium (1)
Kenya (2) · Senegal (1)
Elijah M Songok, PhD (1) · Moustapha Mbow, MD (1) · Pauline N Mwinzi, PhD (1)